Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Direkt zur Navigaton springen.
Direkt zum Inhalt springen.

Navigation/Suche

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Sen, U; Herrmann, M; Herrmann, W; Tyagi, SC.
Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling.
Clin Chem Lab Med. 2007; 45(12):1771-1776 Doi: 10.1515/CCLM.2007.354
Web of Science PubMed FullText FullText_MUG

Co-Autor*innen der Med Uni Graz: Herrmann Markus
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Hyperhomocysteinemia (HHcy) is an independent risk factor of cardiovascular diseases. Extracellular signal-regulated kinase-1/2 (ERK-1/2) and the JAK/STAT pathway kinase, signal transducer and activator of transcription 3 (STAT3), are involved in matrix metalloproteinase-9 (MMP-9) induction and matrix remodeling. However, their role in homocysteine (Hcy)-mediated MMP-9 induction and matrix remodeling is unclear. Clinical and experimental evidence indicates that HHcy and activation of the renin-angiotensin system, mediated by angiotensin II type 1 (AT1) receptor, are involved in a variety of vascular pathologies. Despite this fact, the relationship between HHcy and activation of the renin-angiotensin system has not been comprehensively characterized. Therefore, we hypothesized that Hcy activates AT1 receptor that potentiates STAT3 via ERK-1/2 phosphorylation. STAT3 modulates target MMP-9 and collagen, resulting in vascular remodeling. Mouse aortic endothelial cells (MAEC) were treated with various doses of Hcy for different time periods. The levels of AT1 receptor, ERK-1/2, STAT3, MMP-9 and collagen type-1 were measured by immunoblot analyses. The activation of ERK-1/2 and STAT3 were determined by measuring ERK-1/2 phosphorylation and phosphoserine (727) STAT3. Although Hcy dose-dependently induced AT1 receptor expression in the endothelial cells, a significant induction was observed at 100 microM at 48 h. We investigated Hcy-induced ERK-1/2 and STAT3 phosphorylation through AT1 receptor induction, and our results suggest that Hcy activated AT1 receptor which led to ERK-1/2 and STAT3 phosphorylation. In addition, findings of this study suggest that Hcy-mediated STAT3 activation regulated MMP-9 and collagen type-1. However, AT1 receptor blocker, valsartan, and the specific STAT3 inhibitor peptide attenuated MMP-9 and collagen type-1 induction. These findings demonstrate for the first time the contribution of AT1 receptor in HHcy-induced atherosclerotic diseases; Hcy-induced activation of AT1 receptor involves MMP-9 and collagen type-1 modulation using ERK-1/2 and STAT3 signaling cascades.
Find related publications in this database (using NLM MeSH Indexing): Animals -; Blood Vessels - physiopathology; Blotting, Western -; Cells, Cultured -; Collagen Type I - metabolism; Endothelium, Vascular - enzymology; Endothelium, Vascular - physiopathology; Homocysteine - physiology; Hyperhomocysteinemia - physiopathology; Matrix Metalloproteinase 9 - metabolism; Mice -; Mitogen-Activated Protein Kinase 1 - metabolism; Mitogen-Activated Protein Kinase 3 - metabolism; Receptor, Angiotensin, Type 1 - physiology; STAT3 Transcription Factor - metabolism
Find related publications in this database (Keywords): angiotensin II type 1 (AT1) receptor; collagen type-1; extracellular matrix; extracellular signal-regulated kinase-1/2 (ERK-1/2); matrix metalloproteinase-9 (MMP-9); signal transducer and activator of transcription-3 (STAT3)